Paid Clinical Trials in Texas

Texas has 5,331 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,648 clinical trials

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for Metastatic Castration-resistant Prostate Cancer

Sites in San Antonio +8 more locations

Sponsor: Daiichi Sankyo

Sex: Male·Age: 18+

Code: NCT07244341·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)

for Malignant Neoplasm

Sites in Irving +2 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07247110·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of BI 3810944 in Patients With Advanced Cancer

for Solid Tumours

Sites in Houston +3 more locations

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT07224425·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

for Cardiovascular Disease

Drug: Olpasiran

Sites in Humble +5 more locations

Sponsor: Amgen

Sex: All·Age: 35 - 80

Code: NCT07293260·Phase 3·Recruiting·Listed Dec 2025

Apply to this trial

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

for Geographic Atrophy (GA)

Drug: Pozelimab

Sites in Dallas, Austin +3 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 50+

Code: NCT07230834·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

for Diabetes Mellitus, Type 1

Drug: Baricitinib

Sites in Corpus Christi +4 more locations

Sponsor: Eli Lilly and Company

Sex: All·Age: 1 - 35

Code: NCT07222332·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

for Healthy Volunteers

Sites in San Antonio +2 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07248839·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

Acute Pulmonary Embolism Treatment With the AlphaVac Multipurpose Mechanical Aspiration System and the AlphaReturn Blood Management System: Evaluation of Safety and Effectiveness

for Pulmonary Embolism Acute

Sites in San Antonio, Plano +4 more locations

Sponsor: Angiodynamics, Inc.

Sex: All·Age: 18+

Code: NCT07280247·Recruiting·Listed Dec 2025

Apply to this trial

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

for Advanced-stage Solid Tumors

Sites in Irving +1 more location

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT07223125·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants

for Severe Hepatic Impairment

Drug: Vorasidenib

Sites in San Antonio +2 more locations

Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)

Sex: All·Age: 18 - 75·Accepts healthy volunteers

Code: NCT07250633·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

for Locally Advanced Basal Cell Carcinoma

Sites in Houston +2 more locations

Sponsor: Philogen S.p.A.

Sex: All·Age: 18 - 100

Code: NCT07227350·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

for Depressive Disorder, Major

Sites in Houston +5 more locations

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 12 - 17

Code: NCT07227454·Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston +5 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07226349·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

for PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy

Sites in El Paso +2 more locations

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18+

Code: NCT07226986·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer

for IO-resistant sqNSCLC

Sites in Houston +6 more locations

Sponsor: Takeda

Sex: All·Age: 18+

Code: NCT07217301·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors

for Advanced Squamous Tumors

Sites in Irving +5 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07241039·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

for Locally Advanced Solid Tumor

Sites in Houston, San Antonio +4 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213817·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

for Non-segmental Vitiligo

Sites in Houston +3 more locations

Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.

Sex: All·Age: 18 - 65

Code: NCT07223229·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.

for Advanced Solid Tumors

Sites in Houston, San Antonio +6 more locations

Sponsor: FoRx Therapeutics AG

Sex: All·Age: 18+

Code: NCT07356453·Phase 1·Recruiting·Listed Jan 2026

Apply to this trial

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

for Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy

Drug: Nucresiran

Sites in Houston, Dallas +7 more locations

Sponsor: Alnylam Pharmaceuticals

Sex: All·Age: 18 - 85

Code: NCT07223203·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

for Lymphoma Diffuse Large B-cell

Sites in Houston +4 more locations

Sponsor: AvenCell Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07284433·Phase 1, Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

for Breast Cancer

Sites in Houston, Austin +4 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT07222267·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

for Advanced Solid Tumor

Sites in Houston, San Antonio +4 more locations

Sponsor: Ipsen

Sex: All·Age: 18+

Code: NCT07213830·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea

for Diarrhea

Sites in Rosharon +4 more locations

Sponsor: Bausch Health Americas, Inc.

Sex: All·Age: 6 - 12

Code: NCT07285785·Phase 4·Recruiting·Listed Dec 2025

Apply to this trial

Flourish: Exploring the Early Infant Gut Microbiome

for Microbiota

1 location in Austin

Sponsor: Seeding Inc

Sex: All·Age: 0 Months - 3 Months·Accepts healthy volunteers

Code: NCT07333482·Recruiting·Listed Jan 2026

Apply to this trial

A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

for Muscular Atrophy, Spinal

Sites in Flower Mound +2 more locations

Sponsor: Biogen

Sex: All·Age: 0 Days - 42 Days

Code: NCT07221669·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)

for Relapsed and/or Refractory Multiple Myeloma (RRMM)

Drug: Linvoseltamab

Sites in Houston +3 more locations

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 18+

Code: NCT07222761·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer

for Non Small Cell Lung Cancer (NSCLC)

Sites in Dallas +1 more location

Sponsor: Integro Theranostics

Sex: All·Age: 18+

Code: NCT07276789·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy

for Generalized Lipodystrophy

Sites in Dallas +1 more location

Sponsor: Regeneron Pharmaceuticals

Sex: All·Age: 2+

Code: NCT07220785·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

for Solid Tumors

Sites in Houston +7 more locations

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT07195916·Phase 1·Recruiting·Listed Sep 2025

Apply to this trial

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

for Advanced Solid Malignancies

Sites in San Antonio +3 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07223047·Phase 1, Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

for Stargardt Disease

Sites in Dallas, Bellaire +5 more locations

Sponsor: AAVantgarde Bio Srl

Sex: All·Age: 8 - 55

Code: NCT07161544·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Managing Pain Using Optimized Sequences by Adjusting Parameters With Independent Current Control

for Chronic Pain

Sites in Corpus Christi +6 more locations

Sponsor: Boston Scientific Corporation

Sex: All·Age: 18+

Code: NCT07190807·Recruiting·Listed Sep 2025

Apply to this trial

Nordic Spirit Pouch Nicotine Pharmacokinetics Abuse Liability

for Smoking Behaviors

Sites in San Antonio +1 more location

Sponsor: JT International SA

Sex: All·Age: 22 - 65·Accepts healthy volunteers

Code: NCT07476144·Phase 1·Recruiting·Listed Mar 2026

Apply to this trial

A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.

for Colorectal Cancer

Drug: Atezolizumab

Sites in Texas City +5 more locations

Sponsor: Kahr Bio Australia Pty Ltd

Sex: All·Age: 18+

Code: NCT07235293·Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

for Solid Tumours

Drug: BMS-986517

Sites in San Antonio, Fort Worth +7 more locations

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07160725·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy

for Invasive Mould Infection

Sites in Houston +6 more locations

Sponsor: Elion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07215273·Phase 2·Recruiting·Listed Oct 2025

Apply to this trial

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

for Advanced Solid Tumors

Drug: Sotorasib

Sites in Houston +1 more location

Sponsor: Amgen

Sex: All·Age: 18+

Code: NCT07172919·Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

for Non-small Cell Lung Cancer (NSCLC)

Sites in Dallas +8 more locations

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07140016·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer

for Breast Cancer

Drug: Giredestrant

Sites in San Antonio +1 more location

Sponsor: Genentech, Inc.

Sex: All·Age: 18+

Code: NCT07214662·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial